Cme (CME) Shares Outstanding (Weighted Average) (2009 - 2026)

Cme (CME) has 18 years of Shares Outstanding (Weighted Average) data on file, last reported at $359.3 million in Q1 2026.

• Quarterly Shares Outstanding (Weighted Average) changed 0.08% year-over-year to $359.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $359.3 million (changed 0.08% YoY) and the FY2025 annual result came in at $359.6 million, changed 0.07% from the prior year.
• Shares Outstanding (Weighted Average) was little changed at $359.3 million in Q1 2026 per CME's latest filing, from $359.6 million in the prior quarter.
• Across five years, Shares Outstanding (Weighted Average) topped out at $359.7 million in Q3 2025 and bottomed at $358.6 million in Q1 2022.
• The 5-year median for Shares Outstanding (Weighted Average) is $359.3 million (2024), against an average of $359.2 million.
• The widest annual swing landed in 2022, when Shares Outstanding (Weighted Average) climbed 0.13%; it then dropped 0.08% in 2026.
• Tracing CME's Shares Outstanding (Weighted Average) over 5 years: stood at $358.7 million in 2022, then climbed by 0.09% to $359.0 million in 2023, then gained by 0.1% to $359.4 million in 2024, then advanced by 0.07% to $359.6 million in 2025, then fell by 0.09% to $359.3 million in 2026.
• Per Business Quant, the three latest CME Shares Outstanding (Weighted Average) figures stand at $359.3 million (Q1 2026), $359.6 million (Q4 2025), and $359.7 million (Q3 2025).

Peer Comparison